loading page

Exploring Factors Influencing Patient Activation in Saudi Rheumatoid Arthritis Patients: A Nationwide Cross-Sectional Survey- Results from the COPARA Study
  • +12
  • Haya Mohammed Almalag,
  • Maha M. Alshehri,
  • Nouf A. Altokhais,
  • Ghada A. Aljanobi,
  • Maha I. El Dessougi,
  • Amal Al Harthi,
  • Maha Ahmed Omair,
  • Suzan M. Attar,
  • Sami Bahlas,
  • Abdullah Alfurayj S,
  • Mansour Alazmi ,
  • Alhussain Asiri ,
  • Mohammed M. AlOmair,
  • Lobna AlJuffali,
  • Mohammed Omair
Haya Mohammed Almalag
King Saud University Department of Clinical Pharmacy

Corresponding Author:[email protected]

Author Profile
Maha M. Alshehri
King Saud University College of Pharmacy
Author Profile
Nouf A. Altokhais
King Saud University College of Pharmacy
Author Profile
Ghada A. Aljanobi
Qatif Central Hospital
Author Profile
Maha I. El Dessougi
Security Forces Hospital Program
Author Profile
Amal Al Harthi
Security Forces Hospital Program
Author Profile
Maha Ahmed Omair
King Saud University Department of Statistics and Operations Research
Author Profile
Suzan M. Attar
King Abdulaziz University Faculty of Medicine
Author Profile
Sami Bahlas
King Abdulaziz University Faculty of Medicine
Author Profile
Abdullah Alfurayj S
King Fahd Specialist Hospital Buraidah
Author Profile
Mansour Alazmi
Al-Jouf University College of Medicine
Author Profile
Alhussain Asiri
Aseer Central Hospital
Author Profile
Mohammed M. AlOmair
Aseer Central Hospital
Author Profile
Lobna AlJuffali
King Saud University Department of Clinical Pharmacy
Author Profile
Mohammed Omair
King Saud University Department of Medicine
Author Profile

Abstract

Abstract Objectives: To evaluate patient activation in Rheumatoid Arthritis (RA) patients using the patient activation measure 13 (PAM-13) on a national level in Saudi Arabia. Method: A national survey was administered across multiple centres in Saudi Arabia. The survey assessed patient activation using the PAM-13. The Compliance Questionnaire for Rheumatology (CQR) and the RA Impact of Disease (RAID) tool, were assessed. The data from the survey were analysed, and the results were stratified based on activation level. All factors affecting patient activation were explored and reported. Results: A total of 1241 participants were included. Most of the patients were females (85%), the mean age was 47 (±14), and most patients lived in the central region (47%). The mean (±SD) patient activation score was 578.7 (±13.0). Patient activation was affected by multiple factors: demographic characteristics, such as education, with a beta value of 1.11 (95% CI 0.64 ̵̶ 1.58, p<0.001). Higher CQR scores were associated with higher activation level, with a beta value of 2.61 (95% CI 0.80 ̵̶ 4.44, p=0.005); and higher RAID scores were associated with lower activation levels, with a beta value of 3.13 (95% CI 1.36 ̵̶ 4.91, p=0.001). Conclusions: Patient activation was affected by several demographic characteristics and impact of RA. A higher activation may improve compliance. Future longitudinal studies are required to confirm these findings and should explore the underlying mechanism of these effects.
30 May 2023Submitted to Immunity, Inflammation and Disease
02 Jun 2023Submission Checks Completed
02 Jun 2023Assigned to Editor
02 Jun 2023Review(s) Completed, Editorial Evaluation Pending
13 Jun 2023Reviewer(s) Assigned
09 Sep 2023Editorial Decision: Revise Major
17 Sep 20231st Revision Received
20 Sep 2023Assigned to Editor
20 Sep 2023Submission Checks Completed
20 Sep 2023Review(s) Completed, Editorial Evaluation Pending
30 Sep 2023Reviewer(s) Assigned
02 Nov 2023Editorial Decision: Revise Minor
05 Nov 20232nd Revision Received
06 Nov 2023Assigned to Editor
06 Nov 2023Submission Checks Completed
06 Nov 2023Review(s) Completed, Editorial Evaluation Pending
09 Nov 2023Editorial Decision: Accept